Skip to main content
KoBioLabs, Inc. logo

KoBioLabs, Inc. — Investor Relations & Filings

Ticker · 348150 ISIN · KR7348150004 KO Manufacturing
Open in API
Filings indexed 174 across all filing types
Latest filing 2023-05-16 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 348150

About KoBioLabs, Inc.

http://kobiolabs.com/en/

KoBioLabs, Inc. is a biotechnology company that develops innovative microbiome-based therapeutics. The company utilizes its proprietary Smartiome® platform, an integrated system for discovering novel drug candidates that employs AI-driven multi-omics analysis and a comprehensive microbiome library with a reverse-translation approach. KoBioLabs is focused on creating a pipeline of new drugs to treat a range of immune, metabolic, and brain disorders. The company also applies advanced technologies, including a microbe-based drug delivery system (mDDS) and biofoundry techniques, to enhance the efficacy of its treatments and address unmet medical needs.

Recent filings

Filing Released Lang Actions
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to specific executives, including the number of shares, exercise price, and vesting conditions. This type of disclosure regarding capital structure changes and equity-based compensation for directors/employees falls under the category of 'Share Issue/Capital Change' (SHA) in the provided classification schema.
2023-05-16 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'KoBioLabs' (주식회사 고바이오랩) covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial information, business operations, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-15 Korean
투자판단관련주요경영사항(마이크로바이옴 신약 KBL697 식품의약품안전처 2a 임상시험 계획 승인)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from a Korean company (KoBioLabs) regarding the approval of a Phase 2a clinical trial by the Ministry of Food and Drug Safety (MFDS). It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) in the Korean stock market (KOSPI/KOSDAQ). Since it details a specific regulatory event (clinical trial approval) and does not fit into categories like financial reports, dividends, or board changes, it is classified as a general regulatory filing.
2023-04-24 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (Annual General Meeting). It details the outcomes of voting on agenda items such as financial statement approval, director appointments, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-03-29 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of an outside director (사외이사). This falls under the category of changes in board composition or management structure.
2023-03-29 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for the fiscal year 2022 (Jan 1, 2022 - Dec 31, 2022), filed by KoBioLabs. It contains comprehensive financial and operational information, including company overview, management history, capital structure, and business descriptions. This aligns with the definition of an Annual Report (10-K) in the provided schema, which covers company activity and full financial performance for a fiscal year. FY 2022
2023-03-21 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.